Cancer treatment and monitoring methods using OX40 agonists

Document Type

Patent

Publication Date

8-6-2014

Abstract

OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Location

United States

Comments

Patent Number: 9,828,432

Assignee

PROVIDENCE HEALTH & SERVICES--OREGON (Renton, WA)

Family ID

48947845

Serial Number

14/376,998

Tech ID

12-07-INV

Link to Full Text

Share

COinS